[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BioCentury Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::227778014.png) BioCentury [@BioCentury](/creator/twitter/BioCentury) on x 16.3K followers
Created: 2025-07-25 20:30:12 UTC

In BioCentury's Public Equity Report: Amid a difficult stretch for IPOs, Nanjing Leads Biolabs has priced a HK$1.5B offering in Hong Kong; plus Abivax's $747.5M follow-on, Pfizer's investment in 3SBio and more


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948843248505466949/c:line.svg)

**Related Topics**
[$1530hk](/topic/$1530hk)
[investment](/topic/investment)
[$7475m](/topic/$7475m)
[kong](/topic/kong)
[hong kong](/topic/hong-kong)
[$15b](/topic/$15b)
[stretch for](/topic/stretch-for)

[Post Link](https://x.com/BioCentury/status/1948843248505466949)